Xing B, Yu J, Zhang H, Li Y
The peptide absorbs into surrounding tissue, enters the bloodstream, and starts binding to GLP-1 receptors throughout your body
The biology is complex, and that GLP-1 receptor in the body is not only controlling one thing or doing one thing, but has an intricate web of various effects. This article is exclusive to STAT+ subscribers Unlock this article plus in-depth analysis, newsletters, premium events, and news alerts
If considering a dose reduction for maintenance: Wait until weight has stabilized for at least 4 weeks at your current dose Reduce by one dose step (e.g., 12mg to 8mg), do not jump multiple steps Monitor weight closely for 8 weeks after the reduction If weight begins to increase, return to the previous maintenance dose The phase 3 trials specifically tested 4mg as a maintenance dose, suggesting Lilly sees viability in lower maintenance doses What happens if you stop Weight regain after discontinuing GLP-1 agonists is well documented with semaglutide and tirzepatide
Ive never seen that from a clinic before, and it felt intrusive
What if the missing piece in weight loss wasnt willpower, but the right mix of science, structure, and support
